Publication | Closed Access
Antitumor Effect of <i>bcl-2</i> Antisense Phosphorothioate Oligodeoxynucleotides on Human Renal-Cell Carcinoma Cells <i>in Vitro</i> and in Mice
14
Citations
33
References
2001
Year
Treatment of human RCC with antisense ODNs targeted to bcl-2 inhibits growth and is associated with the induction of programmed cell death. These results suggest therapeutic use of antisense bcl2 in the treatment of RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1